Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable sensors could revolutionize how we track ankylosing spondylitis

NCT ID NCT05570656

Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether wearable motion sensors can accurately measure spinal movement in people with ankylosing spondylitis (AS), a condition that causes back pain and stiffness. Forty participants (20 with AS and 20 healthy volunteers) wore sensors while performing everyday movements like bending and walking. The goal was to see if these sensors could help doctors better track disease activity and mobility loss. The study is complete and focused on developing new measurement tools, not on testing a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better tools for diagnosing and monitoring ankylosing spondylitis using simple wearable sensors.
What could go wrong
This is a small, completed study focused on measurement, not treatment. The findings may not translate into widely used clinical tools without further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Dec 2022

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 * BMI between 18.5 and 30 * Written informed consent * Same gender and age within +/- 3 years compared to an unmatched AS patient Inclusion criteria specific to the AS group: * Age 18-65 * BMI between 18.5 and 30 * Written informed consent * AS meeting the ASAS (Assessment of Spondylo Arthritis International Society) criteria, i.e. with spinal pain ≥ 3 months old, with an age of diagnosis \< 45 years, with: * Sacroiliitis on imaging AND ≥ 1 sign of spondylarthritis. OR * HLA-B27 (human leukocyte antigen-B27) positive AND ≥ 2 other signs of spondylarthritis Exclusion Criteria: * Traumatic, tumoral or infectious low back pain * History of spinal fracture * History of lumbar, pelvis, hips, ankles, and/or knees surgery * Severe scoliosis defined by a Cobb angle \> 50° * Severe impairment of uncorrected visual acuity * Concomitant pathology responsible for ataxia * Lumbar arthrodesis of two or more stages * Pregnant or breastfeeding women * Patient unable to give consent: patient under guardianship or curators, mentally retarded, dementia, language barrier * Patient not affiliated to a social security plan * Patient under legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis spondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ankylosing spondylitis

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.